Peter Garland has become the first patient to receive chimeric antigen receptor T-cell therapy at University Hospital Southampton. He underwent the complex form of cellular therapy which involves collecting and using the patients’ own modified immune cells to treat their condition. Peter, who was diagnosed with lymphoma, originally underwent chemotherapy but after a brief period in remission […]